385 results match your criteria: "'De Gasperis' Cardio Center[Affiliation]"
Eur Heart J Case Rep
May 2024
Interventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milan, Italy.
Background: There is a growing need for percutaneous coronary intervention (PCI) to be performed within the same transcatheter aortic valve implantation (TAVI) procedure. In such cases, cangrelor, a fast-acting intravenous P2Y12-inhibitor with a short offset, is potential clinical utility to minimize bleeding and vascular complications during large-bore arterial access (LBAA) as well as the thrombotic risk associated with concomitant PCI.
Case Summary: We report two cases of TAVI with an indication to concomitant, high-risk PCI.
J Clin Med
April 2024
Cardiology Unit of Emergency Department, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
Europace
May 2024
De Gasperis Cardio Center, Electrophysiology Unit, Niguarda Hospital, Piazza dell'Ospedale Maggiore 3, 20162 Milan, Italy.
Eur Heart J Acute Cardiovasc Care
May 2024
IRCCS San Raffaele Hospital, Cardiovascular Research Center, via Olgettina 60, 20132 Milan, Italy.
Int J Cardiol
July 2024
De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy; University of Milan-Bicocca, School of Medicine and Surgery, Monza, Italy. Electronic address:
Int J Cardiol Heart Vasc
April 2024
"De Gasperis" Cardio Center, Niguarda Hospital, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
J Cardiovasc Med (Hagerstown)
June 2024
Clinica Cardiologica, Dipartimento Toraco-Cardio-Vascolare, Ospedale Maggiore della Carità, Novara.
Background: Atrioventricular block (AVB) is a frequent complication in patients undergoing transcatheter aortic valve implantation (TAVI). Right apex ventricular pacing (RVP) represents the standard treatment but may induce cardiomyopathy over the long term. Left bundle branch area pacing (LBBAP) is a promising alternative, minimizing the risk of desynchrony.
View Article and Find Full Text PDFClin Res Cardiol
April 2024
Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, IRCCS Italian Cardiovascular Network, Largo Rosanna Benzi 10, 16132, Genoa, Italy.
J Clin Med
February 2024
Cardiology Department, Garibaldi Nesima Hospital, 95122 Catania, Italy.
Cardiology
August 2024
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy,
Am J Crit Care
March 2024
Luciano Potena is a physician, Heart Failure and Transplant Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Background: Recent data indicate that end-of-life management for patients affected by acute decompensated heart failure in cardiac intensive care units is aggressive, with late or no engagement of palliative care teams.
Objective: To assess current palliative care and end-of-life practices in a contemporary Italian multicenter registry of patients with cardiogenic shock due to acute decompensated heart failure.
Methods: A survey-based approach was used to collect data on palliative care and end-of-life management practices.
Clin Res Cardiol
April 2024
Department of Cardiology, University Heart and Vascular Center Hamburg, Martinistr. 52, 20251, Hamburg, Germany.
J Am Heart Assoc
February 2024
Robert M. Berne Cardiovascular Research Center and Division of Cardiovascular Medicine, Department of Medicine, Heart and Vascular Center University of Virginia Charlottesville Virginia USA.
Multisystemic inflammatory syndrome in adults is a hyperinflammatory condition following (within 4-12 weeks) SARS-CoV-2 infection. Here, the dysregulation of the immune system leads to a multiorgan involvement often affecting the heart. Cardiac involvement in multisystemic inflammatory syndrome in adults has been described mainly in young men without other comorbidities and may present with different clinical scenarios, including acute heart failure, life-threatening arrhythmias, pericarditis, and myocarditis, with a nonnegligible risk of mortality (up to 7% of all cases).
View Article and Find Full Text PDFCurr Cardiol Rep
March 2024
Cardiovascular Department, Association Socio Sanitary Territorial Santi Paolo e Carlo, Milan, Italy.
Transl Pediatr
January 2024
MOX Laboratory, Department of Mathematics, Politecnico di Milano, Milan, Italy.
Background And Objective: Computational models of the cardiovascular system allow for a detailed and quantitative investigation of both physiological and pathological conditions, thanks to their ability to combine clinical-possibly patient-specific-data with physical knowledge of the processes underlying the heart function. These models have been increasingly employed in clinical practice to understand pathological mechanisms and their progression, design medical devices, support clinicians in improving therapies. Hinging upon a long-year experience in cardiovascular modeling, we have recently constructed a computational multi-physics and multi-scale integrated model of the heart for the investigation of its physiological function, the analysis of pathological conditions, and to support clinicians in both diagnosis and treatment planning.
View Article and Find Full Text PDFJ Cardiovasc Med (Hagerstown)
March 2024
'De Gasperis' Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan.
Circ Heart Fail
February 2024
De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy (E.A., P.G., L.D., G.M., A.V., F. Macera, D.B., L.O., F. Musca, E.P., A.M., F.O., A.G.).
Background: Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. We assessed the ultrasound-assessed internal jugular vein (JV) distensibility by ultrasound as a noninvasive tool to identify patients with normal right atrial pressure (RAP ≤7 mm Hg) in this population.
Methods: We measured JV distensibility as the Valsalva-to-rest ratio of the vein diameter in a calibration cohort (N=100) and a validation cohort (N=101) of consecutive patients with chronic heart failure with reduced ejection fraction who underwent pulmonary artery catheterization for advanced heart failure therapies workup.
J Clin Med
January 2024
1st Division of Cardiology, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.
Catheter-based revascularization procedures were developed as an alternative to systemic thrombolysis for patients with intermediate-high- and high-risk pulmonary embolisms. USAT IH-PE is a retrospective and prospective multicenter registry of such patients treated with ultrasound-facilitated, catheter-directed thrombolysis, whose preliminary results are presented in this study. The primary endpoint was the incidence of pulmonary hypertension (PH) at follow-up.
View Article and Find Full Text PDFJ Clin Med
January 2024
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.
Arrhythmogenic cardiomyopathy (ACM) is a heart disease characterized by a fibrotic replacement of myocardial tissue and a consequent predisposition to ventricular arrhythmic events, especially in the young. Post-mortem studies and the subsequent diffusion of cardiac MRI have shown that left ventricular involvement in arrhythmogenic cardiomyopathy is common and often develops early. Regarding the arrhythmic risk stratification, the current scores underestimate the arrhythmic risk of patients with arrhythmogenic cardiomyopathy with left involvement.
View Article and Find Full Text PDFInt J Cardiol
April 2024
Department of Cardiology and Respiratory Sciences, San Raffaele Cassino (FR), Italy. Electronic address:
Background: A minority of patients with hypertrophic cardiomyopathy (HCM) presents advanced heart failure (HF) during their clinical course, in the context of left ventricular (LV) remodeling with reduced LV ejection fraction (LVEF), or of severe diastolic dysfunction without impaired LVEF. Aim of this study was to describe a multicentric end stage (ES) HCM population and analyze clinical course and outcome among its different phenotypes.
Methods: Data of all HCM patients from 7 Italian referral centres were retrospectively evaluated.
Int J Cardiol
April 2024
De Gasperis Cardio Center, Transplant Center, Niguarda Hospital, Milano, Italy; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy. Electronic address:
Traditional cardiomyopathy paradigms segregate inflammatory etiologies from those caused by genetic variants. An identified or presumed trigger is implicated in acute myocarditis or chronic inflammatory cardiomyopathy but growing evidence suggests a significant proportion of patients have an underlying cardiomyopathy-associated genetic variant often even when a clear inflammatory trigger is identified. Recognizing a possible genetic contribution to inflammatory cardiomyopathy may have major downstream implications for both the patient and family.
View Article and Find Full Text PDFJACC Heart Fail
January 2024
Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy; Department of Medical Sciences, University of Turin, Italy.
Eat Weight Disord
January 2024
Emergency Department, Clinical and Rehabilitation Cardiology Unit, San Filippo Neri Hospital, ASL Roma 1, Rome, Italy.
Obesity is a complex, chronic disease requiring a multidisciplinary approach to its management. In clinical practice, body mass index and waist-related measurements can be used for obesity screening. The estimated prevalence of obesity among adults worldwide is 12%.
View Article and Find Full Text PDFJ Cardiovasc Echogr
November 2023
Cardiology Division, University Hospital Polyclinic G. Martino, University of Messina, Messina, Italy.
Int J Mol Sci
December 2023
Cardiothoracic and Vascular Anesthesia and Intensive Care, AO SS. Antonio e Biagio e Cesare Arrigo, 15100 Alessandria, Italy.
Cardiogenic shock (CS) portends a dismal prognosis if hypoperfusion triggers uncontrolled inflammatory and metabolic derangements. We sought to investigate metabolomic profiles and temporal changes in IL6, Ang-2, and markers of glycocalyx perturbation from admission to discharge in eighteen patients with heart failure complicated by CS (HF-CS). Biological samples were collected from 18 consecutive HF-CS patients at admission (T0), 48 h after admission (T1), and at discharge (T2).
View Article and Find Full Text PDF